MétaCan
Menu
← Back to cohort

Quantification of tumor stroma as a biomarker in pancreatic adenocarcinoma.

2015· article· en· W2601705175 on OpenAlexaff
Robert J. Torphy, Keith E. Volmar, Naim Rashid, Sonia Cader, Julia S. Johansen, Michael A. Hollingsworth, Eric A. Collisson, Jen Jen Yeh

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicPancreatic and Hepatic Oncology Research
Canadian institutionsSurrey Memorial Hospital
Fundersnot available
KeywordsMedicineStromaPrimary tumorAdenocarcinomaPancreatic cancerOncologyMetastasisProportional hazards modelInternal medicineBiomarkerPathologyCancerStage (stratigraphy)Lymph nodeGastroenterologyUrologyImmunohistochemistry

Abstract

fetched live from OpenAlex

4021 Background: Desmoplastic tumor stroma (TS) characterizes the primary tumor in pancreatic ductal adenocarcinoma, but its role in tumor progression and metastasis is less clear. The objective of this study was to evaluate the presence and prognostic significance of TS at primary and metastatic sites. Methods: Tissue sections of primary tumors from 57 patients who underwent curative resections and 46 primary and metastatic tumors from 15 patients with metastatic pancreatic cancer were digitally annotated for tumor epithelium and TS, reviewed by a pathologist, and quantified using Spectrum WebScope. Tumor stroma density (TSD) was quantified as TS per total tumor area. Resected patients received no adjuvant chemotherapy. Association of TSD with overall survival (OS) and recurrence-free survival (RFS) was performed using the multivariate Cox proportional hazards model from the “survival” R statistical package (3.1.1); where significance was determined with log-rank test p-value less than 0.05. Results: Median TSD in primary tumors was 0.57. TSD was no different in the primary tumors of patients who had localized compared to metastatic disease. TSD was decreased in solid organ (0.12) and lymph node metastases (0.22) (ANOVA, p = 0.0001). Furthermore in patients who underwent curative resections, high TSD was associated with longer OS (HR = 0.237; p = 0.009), with a median OS of 11 months in the low TSD ( < 0.57) group and 21.5 months in the high TSD ( ≥ 0.57) group. TSD was also associated with RFS (HR = 0.286, p = 0.022), with a median RFS of 9 months in the low TSD group and 19 months in the high TSD group. The association of TSD with OS and RFS was adjusted for tumor grade, T, N and overall stage, ASA score, and smoking status. Conclusions: We demonstrate that stromal content is a measurable biomarker in this disease with meaningful clinical associations.Our results nominate that TSD should be used as an objective, quantitative assessment of TS in correlative and therapeutic trials of pancreatic cancer. TS appears to be associated with restraining tumor growth with decreasing TSD in patients with more aggressive disease. Also, the low TSD at metastatic sites should be considered in the context of stroma modulating therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.342
GPT teacher head0.538
Teacher spread0.195 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicPancreatic and Hepatic Oncology Research→French-language works237,207→